海外の治験の状況「1」での検索結果
10032件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Concurrent EGFR-TKIs and Thoracic Radiation Therapy in Active EGFR Mutation for 1st Line Treatment of Stage IV NSCLC
- Non Small Cell Lung Cancer
- China
- 2015-01-16
Authorised
- Afatinib as second-line therapy for lung cancer with EGFR mutation
- Metastatic non-small cell lung cancer harbouring an EGFR mutation (Del 19 or L858R) MedDRA version: 17.0 Level: PT Classification code 10029522 Term: Non-small cell lung cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.0 Level: PT Classification code 10029521 Term: Non-small cell lung cancer stage IIIB System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.0 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.0 Level: PT Classification code 10061873 Term: Non-small cell lung cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Algeria, Egypt, Malaysia, Philippines, Poland, Romania, Serbia, Thailand, Tunisia
- 2014-07-02
Not recruiting
- Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
- Germline BRCA1/2 Mutations and;Metastatic Adenocarcinoma of the Pancreas
- Australia, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Netherlands, Spain, United Kingdom, United States
- 2014-06-06
Authorised
- BI 836845 in estrogen receptor positive metastatic breast cancer
- Locally Advanced or Metastatic Breast Cancer positive for estrogen-receptor (ER) and/or progesterone receptor (PgR) and negative for HER2 which is refractory to non-steroidal aromatase inhibitor (letrozole and/or anastrozole) MedDRA version: 16.1 Level: LLT Classification code 10070575 Term: Estrogen receptor positive breast cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, France, Ireland, Korea, Republic of, Netherlands, Spain, Sweden, Taiwan, United Kingdom
- 2014-02-24
Not recruiting
- A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection
- Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics;Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics;Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics;Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics
- Australia, Canada, France, Germany, Italy, New Zealand, Puerto Rico, Russian Federation, Spain, United Kingdom, United States
- 2013-09-06
Not recruiting
- Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
- Newly Diagnosed;Advanced Ovarian Cancer;FIGO Stage III-IV;BRCA Mutation;Complete Response;Partial Response;First Line Platinum Chemotherapy
- Australia, Brazil, Canada, China, France, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, United Kingdom, United States
- 2013-04-30
Recruiting
- Icotinib concurrent thoracic radiotherapy treat for advanced non-small-cell lung cancer (NSCLC) with an activating EGFR gene mutation
- advanced lung adenocarcinoma
- China
- 2016-12-27
Recruiting
- Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)
- Small Cell Lung Cancer;Small Cell Lung Cancer;Small Cell Lung Cancer;Small Cell Lung Cancer
- China
- 2016-12-14
Not Recruiting
- Efficacy and safety of gefitinib plus bevacizumab as first-line therapy in patients with advanced non-small cell lung cancer
- Non-small cell lung cancer
- China
- 2016-12-14
Recruiting
- Determination of HMGB1 levels in serum and cerebrospinal fluid of patients after CA/CPR
- hypoxic-ischemic encephalopathy
- China
- 2016-12-13
Not Recruiting
- A clinical trial intended to assess the Efficacy and Safety of MYL-1402O Compared With Avastin®, in the First-line Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer
- Non-Squamous Non-Small Cell Lung Cancer
- Argentina, Belarus, Bosnia and Herzegovina, Brazil, Bulgaria, Croatia, Georgia, Hungary, India, Indonesia, Italy, Malaysia, Philippines, Poland, Romania, Russian Federation, Spain, Taiwan, Turkey, Ukraine, Viet Nam
- 2016-12-09
Recruiting
- A Prospective Observational Study to Evaluate the dynamic Changes of Serum HMGB1 after Thrombolytic Therapy in Acute Stroke Patients
- Acute ischemic stroke
- China
- 2016-11-30
Recruiting
- Local Therapy in Advanced NSCLC With Non-progressive Disease (PD) After First Line Therapy
- Lung Neoplasms;Lung Neoplasms;Lung Neoplasms;Lung Neoplasms
- China
- 2016-11-29
Not Recruiting
- Phase II study of Compound Formula Realgar-Indigo Naturalis as second-line therapy in late-stage gastric cancer patients
- gastric cancer
- China
- 2016-11-21
Not Recruiting
- Prospective, randomized, non-inferiority study of a new teaching method of B lines derived from simulation: hand ultrasound with wet dressing material
- ;Not Applicable
- Korea, Republic of
- 2016-11-17
Not recruiting
- Study of Surufatinib as Second-line Treatment in Patients With Biliary Tract Carcinoma
- Biliary Tract Cancer
- China
- 2016-11-11
Not recruiting
- Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer
- Progression Free Survival
- China
- 2016-11-05
Not Recruiting
- Study of second line chemotherapy in osteosarcoma based on PDX model drug test
- osteosarcoma
- China
- 2016-10-26
Recruiting
- Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.
- Small Cell Lung Cancer
- China
- 2016-10-25
Not Recruiting
- Investigation the effect of ginger powder on NF-KB, Ox-LDL, lipid profile and clinical symptoms in Rheumatoid arthritis patients
- rheumatoid arthritis. Rheumatoid arthritis with splenoadenomegaly and leukopenia;Rheumatoid arthritis with splenoadenomegaly and leukopenia
- Iran (Islamic Republic of)
- 2016-10-08
